Reinnervate has been accepted as a new member of the In Vitro Testing Industrial Platform (IVTIP). The Company joins a group of over 35 organisations from across Europe actively involved in developing technologies for in vitro testing with the aim of replacing, reducing and refining animal testing.
The UVTIP was set up in 1993 to advise European bodies (European Commission, European Parliament) on the industrial requirements for current and future research projects in in vitro testing. Membership is excellent validation of Alvetex®, Reinnervate’s unique technology enabling routine 3D tissue culture, as a valid alternative to animal testing for applications such as drug toxicity testing and testing cosmetics and topically applied drugs.
Note: Reinnervate Ltd (County Durham, England) was acquired by REPROCELL Inc (Yokohama, Japan) in August 2014. Biopta Ltd (Glasgow, Scotland) was acquired by REPROCELL in November 2015. REPROCELL Europe Ltd was established by merging Reinnervate and Biopta in June 2016.
